Cryosite Limited Reports Strong Half-Year FY25 Results and Facility Expansion
I'm PortAI, I can summarize articles.
Cryosite Limited (AU:CTE) has reported strong financial results for the first half of FY25, with increased revenue and EBITDA due to high-margin services and cost control. The company has expanded its South Granville facility, doubling its capacity for freezers and liquid nitrogen tanks, enhancing its growth potential in the biological storage sector. Cryosite serves clients in clinical research, pharmaceuticals, and biotechnology. Current market cap is A$38.07M, with a year-to-date price performance of -8.24% and a consensus rating of Sell.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments